http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#head http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#assertion http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#provenance http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#assertion http://rdf.disgenet.org/resource/gda/DGN3a6657dce118ec4da73e97f03f35fdb4 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/1814 http://rdf.disgenet.org/resource/gda/DGN3a6657dce118ec4da73e97f03f35fdb4 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0040822 http://rdf.disgenet.org/resource/gda/DGN3a6657dce118ec4da73e97f03f35fdb4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001121 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#provenance http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#assertion http://purl.org/dc/terms/description [The gain-of-function produced by the Gly-9 variant may explain why drugs active against tremor in Parkinson's disease (PD) are usually not effective in the treatment of ET and suggests that DRD3 partial agonists or antagonists should be considered as novel therapeutic options for patients with ET.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/16809426 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/dc/terms/created 2017-10-17T13:12:05+02:00 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP300739.RA2DDhbTUxxs18FCosIsnYYwsWMrSnQxTNsqOg7CmNsV0 http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0